Immunicum AB (publ) April – Juni 2021 i Sammandrag
August 26, 2021 02:00 ET | Immunicum AB
Pressmeddelande 26 August 2021 Immunicum AB (publ) April – Juni 2021 i Sammandrag  Nettoomsättning för kvartalet uppgick till - (-).Periodens resultat uppgick till KSEK -31,278...
Immunicum AB (publ) Interim Report April - June 2021
August 26, 2021 02:00 ET | Immunicum AB
Press Release 26 August 2021 Immunicum AB (publ) Interim Report April - June 2021 FINANCIAL SUMMARY FOR THE QUARTER APRIL - JUNE Net sales for the period amounted to -...
Immunicum Receives Advanced Therapy Medicinal Product Classification from the EMA for Cancer Relapse Vaccine Candidate DCP-001
June 28, 2021 02:00 ET | Immunicum AB
Press Release 28 June 2021 Immunicum Receives Advanced Therapy Medicinal Product Classification from the EMA for Cancer Relapse Vaccine Candidate DCP-001 Immunicum AB (publ) today announced that...
Immunicum erhåller Advanced Therapy Medicinal Product-klassificering från EMA för vaccinkandidaten mot canceråterfall, DCP-001
June 28, 2021 02:00 ET | Immunicum AB
Pressmeddelande 28 Juni 2021 Immunicum erhåller Advanced Therapy Medicinal Product-klassificering från EMA för vaccinkandidaten mot canceråterfall, DCP-001 Immunicum AB tillkännagav idag att...
Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer Relapse Vaccine Candidate DCP-001 in Ovarian Cancer
June 23, 2021 02:00 ET | Immunicum AB
Press Release 23 June 2021 Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer Relapse Vaccine Candidate DCP-001 in Ovarian Cancer - First study...
Immunicum tillkännager inkludering av den första patienten i fas I ALISON-studien som utvärderar vaccinkandidaten DCP-001 vid äggstockscancer
June 23, 2021 02:00 ET | Immunicum AB
Pressrelease 23 juni, 2021 Immunicum tillkännager inkludering av den första patienten i fas I ALISON-studien som utvärderar vaccinkandidaten DCP-001 vid äggstockscancer - Första studien för...
Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress
June 11, 2021 03:03 ET | Immunicum AB
Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress -- Ongoing ADVANCE II study evaluating DCP-001 in AML patients is nearing...
Immunicum presenterar data från det kliniska programmet DCP-001 vid European Hematology Association (EHA) 2021 Virtual Congress 
June 11, 2021 03:03 ET | Immunicum AB
Immunicum presenterar data från det kliniska programmet DCP-001 vid European Hematology Association (EHA) 2021 Virtual Congress  - Den pågående ADVANCE-II-studien, som utvärderar DCP-001 hos...
Immunicum håller presentationer vid European Hematology Association (EHA) 2021 Virtual Congress
May 12, 2021 10:02 ET | Immunicum AB
Pressrelease 12 maj 2021 Immunicum håller presentationer vid European Hematology Association (EHA) 2021 Virtual Congress Immunicum AB (publ; IMMU.ST) tillkännagav idag att bolaget kommer att...
Immunicum Announces Presentations at the European Hematology Association (EHA) 2021 Virtual Congress
May 12, 2021 10:02 ET | Immunicum AB
Press Release 12 May 2021 Immunicum Announces Presentations at the European Hematology Association (EHA) 2021 Virtual Congress Immunicum AB (publ; IMMU.ST) today announced that it will be...